ÂÜÀòÂÒÂ×

Sylvie Godefroy has a diverse range of work experience spanning over two decades. Sylvie began their career as a Doctoral Researcher at the Centre d'immunologie Pierre Fabre and INSERM U346 in 1999. Sylvie then worked as a Post-doctoral Researcher at CNRS - Centre national de la recherche scientifique from 2003 to 2005. Sylvie transitioned to the role of Researcher R&D at DBV Technologies from 2006 to 2008. Sylvie then worked as a Scientific Writer at ENDOTIS PHARMA from 2009 to 2010. Sylvie served as a Project Manager at Invectys from 2010 to 2011. In 2012, they took on the role of R&D Manager at Immuno Targets until 2015. Sylvie later became the R&D Manager at ElyssaMed SAS for a brief period in 2016. Sylvie also worked as a Scientific Project Manager at Coopetic from 2016 to 2020. Sylvie then served as a consultant and provided support for scientific projects at 3i Biosciences from 2017 until the present. Currently, Sylvie holds the position of Office and Operations Manager at Apmonia Therapeutics from April 2022 onwards. Throughout their career, Sylvie has demonstrated their expertise in research, project management, and scientific writing.

Sylvie Godefroy attended the University of Rouen, although the start and end years of their enrollment are not specified. Sylvie then pursued a Master's degree in Cutaneous Biology and Pharmacology at the Université Claude Bernard Lyon 1 from 1998 to 1999. Sylvie continued their education at the same university and obtained a PhD in Immunology from 1999 to 2002. In 2007, Sylvie briefly studied at the Université Paris Cité for a degree related to experiments on animals, but the specific degree name is not provided.